Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma
about
Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma
description
clinical trial
@en
klinisch onderzoek
@nl
name
Vorinostat and Bortezomib in T ...... ous System Tumors and Lymphoma
@en
type
label
Vorinostat and Bortezomib in T ...... ous System Tumors and Lymphoma
@en
prefLabel
Vorinostat and Bortezomib in T ...... ous System Tumors and Lymphoma
@en
P1050
P1050
P1476
A Phase I Study of Vorinostat ...... uding CNS Tumors and Lymphomas
@en
P3098
NCT00994500
P4844
P580
2009-08-01T00:00:00Z
P582
2011-07-01T00:00:00Z